醋酸哌替洛尔
醋酸哌替洛尔结构式
|
常用名 | 醋酸哌替洛尔 | 英文名 | Pirbuterol Acetate |
|---|---|---|---|---|
| CAS号 | 65652-44-0 | 分子量 | 300.35100 | |
| 密度 | N/A | 沸点 | 489.3ºC at 760 mmHg | |
| 分子式 | C14H24N2O5 | 熔点 | 129-132 °C | |
| MSDS | 美版 | 闪点 | 249.7ºC |
|
Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000-2009 period.
Eur. J. Clin. Pharmacol. 66(9) , 929-36, (2010) The objective of this study was to analyse inter-and intra-country quantitative and qualitative differences in anti-asthmatic prescriptions to children and adolescents.A literature search was performed in EMBASE and MEDLINE to identify pharmaco-epidemiologica... |
|
|
The utility of the forced oscillation technique in assessing bronchodilator responsiveness in patients with asthma.
Respir. Med. 101(5) , 995-1000, (2007) To address the utility of the forced oscillation technique (FOT) in assessing bronchodilator responsiveness compared with forced expiratory volume in 1s (FEV(1)).This is a retrospective analysis of consecutive 126 patients with a clinical history of asthma wi... |
|
|
The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers.
Clin. Ther. 21(1) , 236-53, (1999) This paper reviews the impact of the use of technologically dissimilar beta-agonist aerosols--the Maxair Autohaler (pirbuterol acetate) breath-actuated aerosol and the traditional albuterol press-and-breathe inhaler-on the treatment costs of asthma. If, as cl... |
|
|
Ease-of-use study of pirbuterol acetate in the Autohaler actuator in three countries: the United States, Germany, and France.
J. Asthma 30(6) , 439-43, (1993) The preferred form of acute bronchodilator therapy is to administer aerosolized beta-agonist by a metered-dose inhaler. Many patients cannot use this device efficiently, the major problem being coordination of dose release with inspiration. A new breath-actua... |
|
|
Double-blind, clinical efficacy study comparing 400 micrograms of pirbuterol versus placebo delivered by a breath-actuated aerosol inhaler.
J. Asthma 31(3) , 187-92, (1994) Pirbuterol is a selective beta-2 adrenergic agonist that is indicated for the treatment of bronchospasm in patients with asthma. Traditionally, the most common form of administration of the beta-2 agonist is by inhalation from a pressurized metered-dose inhal... |
|
|
The use of two inhaled beta agonists for the treatment of COPD: a summary of European data.
J. Asthma 30(2) , 123-6, (1993)
|
|
|
Management of chronic obstructive pulmonary disease.
N. Engl. J. Med. 329(13) , 967-8, (1993)
|
|
|
Paradoxical asthma hazard of short-acting beta2-agonists.
Allergy 63(2) , 241, (2008)
|
|
|
[Pirbuterol: a new beta 2-sympathomimetic agent. An open multicenter study].
Therapie. 46(3) , 253-4, (1991)
|
|
|
Salbutamol, terbutaline and pirbuterol allergy in an asthmatic patient.
Allergy 62(10) , 1219-20, (2007)
|